0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autoimmune Disorder Drug Delivery Devices Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2M8494
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autoimmune Disorder Drug Delivery Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global Autoimmune Disorder Drug Delivery Devices Market Research Report 2025

Code: QYRE-Auto-2M8494
Report
July 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Autoimmune Disorder Drug Delivery Devices Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Autoimmune Disorder Drug Delivery Devices Market

Autoimmune Disorder Drug Delivery Devices Market

The global market for Autoimmune Disorder Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Autoimmune Disorder Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disorder Drug Delivery Devices.
The Autoimmune Disorder Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Disorder Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disorder Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Autoimmune Disorder Drug Delivery Devices Market Report

Report Metric Details
Report Name Autoimmune Disorder Drug Delivery Devices Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BD, Gerresheimer, Schott, J.O.Pharma, Nipro, Roselabs, Fresenius Kabi, Baxter, West Pharma, Terumo, Taisei Kako, MedXL, Cardinal Health, Guerbet, Catalent, Weigao, Stevanato, Rovi CM, Zibo Minkang, Vetter Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Autoimmune Disorder Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Autoimmune Disorder Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Autoimmune Disorder Drug Delivery Devices Market report?

Ans: The main players in the Autoimmune Disorder Drug Delivery Devices Market are BD, Gerresheimer, Schott, J.O.Pharma, Nipro, Roselabs, Fresenius Kabi, Baxter, West Pharma, Terumo, Taisei Kako, MedXL, Cardinal Health, Guerbet, Catalent, Weigao, Stevanato, Rovi CM, Zibo Minkang, Vetter Pharma

What are the Application segmentation covered in the Autoimmune Disorder Drug Delivery Devices Market report?

Ans: The Applications covered in the Autoimmune Disorder Drug Delivery Devices Market report are Hospital, Clinic

What are the Type segmentation covered in the Autoimmune Disorder Drug Delivery Devices Market report?

Ans: The Types covered in the Autoimmune Disorder Drug Delivery Devices Market report are Pen Injectors, Auto-Injectors, Pre-filled Syringes, Vials

Recommended Reports

Drug Delivery Devices

Autoimmune Disorder Drugs

Therapy and Treatment Devices

1 Autoimmune Disorder Drug Delivery Devices Market Overview
1.1 Product Definition
1.2 Autoimmune Disorder Drug Delivery Devices by Type
1.2.1 Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pen Injectors
1.2.3 Auto-Injectors
1.2.4 Pre-filled Syringes
1.2.5 Vials
1.3 Autoimmune Disorder Drug Delivery Devices by Application
1.3.1 Global Autoimmune Disorder Drug Delivery Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Autoimmune Disorder Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Autoimmune Disorder Drug Delivery Devices Revenue 2020-2031
1.4.2 Global Autoimmune Disorder Drug Delivery Devices Sales 2020-2031
1.4.3 Global Autoimmune Disorder Drug Delivery Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Autoimmune Disorder Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Autoimmune Disorder Drug Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Autoimmune Disorder Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Date of Enter into This Industry
2.8 Global Autoimmune Disorder Drug Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Autoimmune Disorder Drug Delivery Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Autoimmune Disorder Drug Delivery Devices Players Market Share by Revenue
2.8.3 Global Autoimmune Disorder Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Autoimmune Disorder Drug Delivery Devices Market Scenario by Region
3.1 Global Autoimmune Disorder Drug Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Region: 2026-2031
3.3 Global Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2026-2031
3.4 North America Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2020-2031)
4.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2020-2031)
4.3 Global Autoimmune Disorder Drug Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2020-2031)
5.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2020-2031)
5.3 Global Autoimmune Disorder Drug Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Gerresheimer
6.2.1 Gerresheimer Company Information
6.2.2 Gerresheimer Description and Business Overview
6.2.3 Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gerresheimer Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.2.5 Gerresheimer Recent Developments/Updates
6.3 Schott
6.3.1 Schott Company Information
6.3.2 Schott Description and Business Overview
6.3.3 Schott Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Schott Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.3.5 Schott Recent Developments/Updates
6.4 J.O.Pharma
6.4.1 J.O.Pharma Company Information
6.4.2 J.O.Pharma Description and Business Overview
6.4.3 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.4.5 J.O.Pharma Recent Developments/Updates
6.5 Nipro
6.5.1 Nipro Company Information
6.5.2 Nipro Description and Business Overview
6.5.3 Nipro Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nipro Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.5.5 Nipro Recent Developments/Updates
6.6 Roselabs
6.6.1 Roselabs Company Information
6.6.2 Roselabs Description and Business Overview
6.6.3 Roselabs Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roselabs Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.6.5 Roselabs Recent Developments/Updates
6.7 Fresenius Kabi
6.7.1 Fresenius Kabi Company Information
6.7.2 Fresenius Kabi Description and Business Overview
6.7.3 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Baxter
6.8.1 Baxter Company Information
6.8.2 Baxter Description and Business Overview
6.8.3 Baxter Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Baxter Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.8.5 Baxter Recent Developments/Updates
6.9 West Pharma
6.9.1 West Pharma Company Information
6.9.2 West Pharma Description and Business Overview
6.9.3 West Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 West Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.9.5 West Pharma Recent Developments/Updates
6.10 Terumo
6.10.1 Terumo Company Information
6.10.2 Terumo Description and Business Overview
6.10.3 Terumo Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Terumo Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.10.5 Terumo Recent Developments/Updates
6.11 Taisei Kako
6.11.1 Taisei Kako Company Information
6.11.2 Taisei Kako Description and Business Overview
6.11.3 Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Taisei Kako Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.11.5 Taisei Kako Recent Developments/Updates
6.12 MedXL
6.12.1 MedXL Company Information
6.12.2 MedXL Description and Business Overview
6.12.3 MedXL Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 MedXL Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.12.5 MedXL Recent Developments/Updates
6.13 Cardinal Health
6.13.1 Cardinal Health Company Information
6.13.2 Cardinal Health Description and Business Overview
6.13.3 Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Cardinal Health Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.13.5 Cardinal Health Recent Developments/Updates
6.14 Guerbet
6.14.1 Guerbet Company Information
6.14.2 Guerbet Description and Business Overview
6.14.3 Guerbet Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Guerbet Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.14.5 Guerbet Recent Developments/Updates
6.15 Catalent
6.15.1 Catalent Company Information
6.15.2 Catalent Description and Business Overview
6.15.3 Catalent Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Catalent Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.15.5 Catalent Recent Developments/Updates
6.16 Weigao
6.16.1 Weigao Company Information
6.16.2 Weigao Description and Business Overview
6.16.3 Weigao Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Weigao Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.16.5 Weigao Recent Developments/Updates
6.17 Stevanato
6.17.1 Stevanato Company Information
6.17.2 Stevanato Description and Business Overview
6.17.3 Stevanato Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Stevanato Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.17.5 Stevanato Recent Developments/Updates
6.18 Rovi CM
6.18.1 Rovi CM Company Information
6.18.2 Rovi CM Description and Business Overview
6.18.3 Rovi CM Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Rovi CM Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.18.5 Rovi CM Recent Developments/Updates
6.19 Zibo Minkang
6.19.1 Zibo Minkang Company Information
6.19.2 Zibo Minkang Description and Business Overview
6.19.3 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.19.5 Zibo Minkang Recent Developments/Updates
6.20 Vetter Pharma
6.20.1 Vetter Pharma Company Information
6.20.2 Vetter Pharma Description and Business Overview
6.20.3 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.20.5 Vetter Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autoimmune Disorder Drug Delivery Devices Industry Chain Analysis
7.2 Autoimmune Disorder Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autoimmune Disorder Drug Delivery Devices Production Mode & Process Analysis
7.4 Autoimmune Disorder Drug Delivery Devices Sales and Marketing
7.4.1 Autoimmune Disorder Drug Delivery Devices Sales Channels
7.4.2 Autoimmune Disorder Drug Delivery Devices Distributors
7.5 Autoimmune Disorder Drug Delivery Devices Customer Analysis
8 Autoimmune Disorder Drug Delivery Devices Market Dynamics
8.1 Autoimmune Disorder Drug Delivery Devices Industry Trends
8.2 Autoimmune Disorder Drug Delivery Devices Market Drivers
8.3 Autoimmune Disorder Drug Delivery Devices Market Challenges
8.4 Autoimmune Disorder Drug Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Autoimmune Disorder Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Autoimmune Disorder Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Autoimmune Disorder Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Autoimmune Disorder Drug Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Autoimmune Disorder Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Autoimmune Disorder Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorder Drug Delivery Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Autoimmune Disorder Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Autoimmune Disorder Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Autoimmune Disorder Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Autoimmune Disorder Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Autoimmune Disorder Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Autoimmune Disorder Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Autoimmune Disorder Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Application (2026-2031)
 Table 70. BD Company Information
 Table 71. BD Description and Business Overview
 Table 72. BD Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. BD Autoimmune Disorder Drug Delivery Devices Product
 Table 74. BD Recent Developments/Updates
 Table 75. Gerresheimer Company Information
 Table 76. Gerresheimer Description and Business Overview
 Table 77. Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Gerresheimer Autoimmune Disorder Drug Delivery Devices Product
 Table 79. Gerresheimer Recent Developments/Updates
 Table 80. Schott Company Information
 Table 81. Schott Description and Business Overview
 Table 82. Schott Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Schott Autoimmune Disorder Drug Delivery Devices Product
 Table 84. Schott Recent Developments/Updates
 Table 85. J.O.Pharma Company Information
 Table 86. J.O.Pharma Description and Business Overview
 Table 87. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product
 Table 89. J.O.Pharma Recent Developments/Updates
 Table 90. Nipro Company Information
 Table 91. Nipro Description and Business Overview
 Table 92. Nipro Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Nipro Autoimmune Disorder Drug Delivery Devices Product
 Table 94. Nipro Recent Developments/Updates
 Table 95. Roselabs Company Information
 Table 96. Roselabs Description and Business Overview
 Table 97. Roselabs Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Roselabs Autoimmune Disorder Drug Delivery Devices Product
 Table 99. Roselabs Recent Developments/Updates
 Table 100. Fresenius Kabi Company Information
 Table 101. Fresenius Kabi Description and Business Overview
 Table 102. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product
 Table 104. Fresenius Kabi Recent Developments/Updates
 Table 105. Baxter Company Information
 Table 106. Baxter Description and Business Overview
 Table 107. Baxter Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Baxter Autoimmune Disorder Drug Delivery Devices Product
 Table 109. Baxter Recent Developments/Updates
 Table 110. West Pharma Company Information
 Table 111. West Pharma Description and Business Overview
 Table 112. West Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. West Pharma Autoimmune Disorder Drug Delivery Devices Product
 Table 114. West Pharma Recent Developments/Updates
 Table 115. Terumo Company Information
 Table 116. Terumo Description and Business Overview
 Table 117. Terumo Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Terumo Autoimmune Disorder Drug Delivery Devices Product
 Table 119. Terumo Recent Developments/Updates
 Table 120. Taisei Kako Company Information
 Table 121. Taisei Kako Description and Business Overview
 Table 122. Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Taisei Kako Autoimmune Disorder Drug Delivery Devices Product
 Table 124. Taisei Kako Recent Developments/Updates
 Table 125. MedXL Company Information
 Table 126. MedXL Description and Business Overview
 Table 127. MedXL Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. MedXL Autoimmune Disorder Drug Delivery Devices Product
 Table 129. MedXL Recent Developments/Updates
 Table 130. Cardinal Health Company Information
 Table 131. Cardinal Health Description and Business Overview
 Table 132. Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Cardinal Health Autoimmune Disorder Drug Delivery Devices Product
 Table 134. Cardinal Health Recent Developments/Updates
 Table 135. Guerbet Company Information
 Table 136. Guerbet Description and Business Overview
 Table 137. Guerbet Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Guerbet Autoimmune Disorder Drug Delivery Devices Product
 Table 139. Guerbet Recent Developments/Updates
 Table 140. Catalent Company Information
 Table 141. Catalent Description and Business Overview
 Table 142. Catalent Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Catalent Autoimmune Disorder Drug Delivery Devices Product
 Table 144. Catalent Recent Developments/Updates
 Table 145. Weigao Company Information
 Table 146. Weigao Description and Business Overview
 Table 147. Weigao Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Weigao Autoimmune Disorder Drug Delivery Devices Product
 Table 149. Weigao Recent Developments/Updates
 Table 150. Stevanato Company Information
 Table 151. Stevanato Description and Business Overview
 Table 152. Stevanato Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Stevanato Autoimmune Disorder Drug Delivery Devices Product
 Table 154. Stevanato Recent Developments/Updates
 Table 155. Rovi CM Company Information
 Table 156. Rovi CM Description and Business Overview
 Table 157. Rovi CM Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Rovi CM Autoimmune Disorder Drug Delivery Devices Product
 Table 159. Rovi CM Recent Developments/Updates
 Table 160. Zibo Minkang Company Information
 Table 161. Zibo Minkang Description and Business Overview
 Table 162. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product
 Table 164. Zibo Minkang Recent Developments/Updates
 Table 165. Vetter Pharma Company Information
 Table 166. Vetter Pharma Description and Business Overview
 Table 167. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product
 Table 169. Vetter Pharma Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Autoimmune Disorder Drug Delivery Devices Distributors List
 Table 173. Autoimmune Disorder Drug Delivery Devices Customers List
 Table 174. Autoimmune Disorder Drug Delivery Devices Market Trends
 Table 175. Autoimmune Disorder Drug Delivery Devices Market Drivers
 Table 176. Autoimmune Disorder Drug Delivery Devices Market Challenges
 Table 177. Autoimmune Disorder Drug Delivery Devices Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Autoimmune Disorder Drug Delivery Devices
 Figure 2. Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Autoimmune Disorder Drug Delivery Devices Market Share by Type: 2024 & 2031
 Figure 4. Pen Injectors Product Picture
 Figure 5. Auto-Injectors Product Picture
 Figure 6. Pre-filled Syringes Product Picture
 Figure 7. Vials Product Picture
 Figure 8. Global Autoimmune Disorder Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Autoimmune Disorder Drug Delivery Devices Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Global Autoimmune Disorder Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Autoimmune Disorder Drug Delivery Devices Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Autoimmune Disorder Drug Delivery Devices Sales (2020-2031) & (K Units)
 Figure 15. Global Autoimmune Disorder Drug Delivery Devices Average Price (US$/Unit) & (2020-2031)
 Figure 16. Autoimmune Disorder Drug Delivery Devices Report Years Considered
 Figure 17. Autoimmune Disorder Drug Delivery Devices Sales Share by Manufacturers in 2024
 Figure 18. Global Autoimmune Disorder Drug Delivery Devices Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Autoimmune Disorder Drug Delivery Devices Players: Market Share by Revenue in Autoimmune Disorder Drug Delivery Devices in 2024
 Figure 20. Autoimmune Disorder Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Autoimmune Disorder Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 23. North America Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 24. United States Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 27. Europe Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2020-2031)
 Figure 35. China Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Autoimmune Disorder Drug Delivery Devices by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Devices by Type (2020-2031)
 Figure 56. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Autoimmune Disorder Drug Delivery Devices by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Devices by Application (2020-2031)
 Figure 59. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Application (2020-2031)
 Figure 60. Autoimmune Disorder Drug Delivery Devices Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS